Neurobehavioral radiation mitigation to standard brain cancer therapy regimens by Mn(III)n-butoxyethylpyridylporphyrin-based redox modifier

MLA

James E. Herndon, et al. “Neurobehavioral Radiation Mitigation to Standard Brain Cancer Therapy Regimens by Mn(III)n-Butoxyethylpyridylporphyrin-Based Redox Modifier.” Environmental and Molecular Mutagenesis, vol. 57, May 2016, pp. 372–81. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........0528ebaab5c53e777b7015678fb9d69b&authtype=sso&custid=ns315887.

APA

James E. Herndon, Kathleen A. Ashcraft, Alina Boico, Ramona M. Rodriguiz, Ines Batinic-Haberle, Samuel R. Birer, Douglas H. Weitzel, Kingshuk Roy Choudhury, Katherine B. Peters, William C. Wetsel, Mark W. Dewhirst, Artak Tovmasyan, & Ivan Spasojevic. (2016). Neurobehavioral radiation mitigation to standard brain cancer therapy regimens by Mn(III)n-butoxyethylpyridylporphyrin-based redox modifier. Environmental and Molecular Mutagenesis, 57, 372–381.

Chicago

James E. Herndon, Kathleen A. Ashcraft, Alina Boico, Ramona M. Rodriguiz, Ines Batinic-Haberle, Samuel R. Birer, Douglas H. Weitzel, et al. 2016. “Neurobehavioral Radiation Mitigation to Standard Brain Cancer Therapy Regimens by Mn(III)n-Butoxyethylpyridylporphyrin-Based Redox Modifier.” Environmental and Molecular Mutagenesis 57 (May): 372–81. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........0528ebaab5c53e777b7015678fb9d69b&authtype=sso&custid=ns315887.